In this expert panel discussion on February 26, Rentschler Biopharma’s experts share real‑world lessons from supporting ...

Cytotheryx, a preclinical cell therapy company developing treatments for liver disease, is receiving $60 million in Series A ...

Vaximm, which specializes in oral T-cell immunotherapies for cancer, is naming Sébastien Wieckowski, PhD, Chief Scientific ...

Apiject Holdings Inc. has signed a lease for a 30,000-square-foot pharmaceutical manufacturing facility in Apex, North ...

Avid Bioservices, a contract development and manufacturing organization (CDMO), has appointed Rich McAvoy as Chief Business Officer (CBO).

MGS, a provider of end-to-end healthcare solutions, has launched the A.i.r. Platform, a customizable auto-injector platform ...

Harald Hampel is recognized as an influential leader in neuroscience, and will bring expertise in Alzheimer's disease to BMS.

Vetter, a globally operating CDMO, has completed several important steps in the ongoing development and upcoming launch of V-OVS® next.

Kindeva, a global contract development and manufacturing organization (CDMO) and drug delivery innovator, has appointed David ...

The advent and proliferation of targeted modalities represent an evolutionary leap forward in drug development. By binding ...

Immunai, an AI biotech company specializing in mapping the human immune system, has announced a strategic collaboration with ...

Zydus Lifesciences Limited, an innovation-led life-sciences company with an international presence, has closed its ...